argenx SE | ARGX - Ativo Circulante





Ativo Circulante Alterar Data
AstraZeneca USD 29.61B 890M 2026-03
Genmab DKK 2.88B 1.59B 2025-12
GlaxoSmithKline GBP 17.76B 251M 2026-03
GRIFOLS EUR 5.25B 180M 2026-03
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Lakefront Biotherapeutics EUR 3.06B 18.72M 2026-03
Qiagen NV USD 2B 535.87M 2025-12
UCB EUR 6.05B 733M 2025-12